Empagliflozin: Potential Protective Effects on Hepatocytes and Liver Outcomes in Streptozotocin -Diabetic Rats.
Open Access
- 31 December 2023
- journal article
- research article
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 16 (4) , 2123-2133
Abstract
Biomedical and Pharmacology Journal (BPJ) is an international, open access, peer reviewed, quarterly research journal.Keywords
This publication has 59 references indexed in Scilit:
- Diabetes mellitus and oxidative stress—A concise reviewSaudi Pharmaceutical Journal, 2016
- What the Papers SaidBritish Journalism Review, 2016
- The SGLT2 inhibitor empagliflozin improves insulin sensitivity in db/db mice both as monotherapy and in combination with linagliptinMetabolism, 2016
- Statins Increase Mitochondrial and Peroxisomal Fatty Acid Oxidation in the Liver and Prevent Non-Alcoholic Steatohepatitis in MiceDiabetes & Metabolism Journal, 2016
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 DiabetesNew England Journal of Medicine, 2015
- Hepatic ALT isoenzymes are elevated in gluconeogenic conditions including diabetes and suppressed by insulin at the protein levelDiabetes/Metabolism Research and Reviews, 2015
- Efficacy and safety of empagliflozin for type 2 diabetes: a systematic review and meta‐analysisDiabetes, Obesity and Metabolism, 2014
- Serum Biochemical, Histopathology and SEM Analyses of the Effects of the Indian Traditional Herb Wattakaka Volubilis Leaf Extract on Wistar Male RatsJournal of Pharmacopuncture, 2014
- Oxidative Stress in Diabetes: Implications for Vascular and Other ComplicationsInternational Journal of Molecular Sciences, 2013
- Mechanisms of Diabetic ComplicationsPhysiological Reviews, 2013